NTES-S
09999
JD HEALTH
06618
TRIP.COM-S
09961
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
(FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 183.31%232.7M | ---- | -316.69%-279.32M | ---- | 209.25%128.9M | ---- | 89.62%-117.99M | ---- | -304.65%-1.14B | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -22.19%-35.38M | ---- | -2.52%-28.95M | ---- | 16.46%-28.24M | ---- | ---33.8M | ---- | ---- | ---- |
Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---59.89M | ---- | ---- | ---- | ---- | ---- |
Investment loss (gain) | 99.17%78.62M | ---- | 267.22%39.47M | ---- | 186.56%10.75M | ---- | -73.96%3.75M | ---- | 47.51%14.41M | ---- |
Impairment and provisions: | 111.27%392.08M | ---- | -59.35%185.59M | ---- | 76.79%456.58M | ---- | -65.62%258.26M | ---- | 2,549.76%751.13M | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | --7.61M | ---- | ---- | ---- | --53.57M | ---- |
-Impairment of trade receivables (reversal) | 94,091.07%52.64M | ---- | -100.03%-56K | ---- | 22.46%176.15M | ---- | -62.32%143.84M | ---- | 1,850.83%381.72M | ---- |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 66.34%34.93M | ---- |
-Other impairments and provisions | 82.85%339.44M | ---- | -31.96%185.64M | ---- | 138.46%272.82M | ---- | -59.27%114.41M | ---- | 863.69%280.91M | ---- |
Revaluation surplus: | -77.71%31.81M | ---- | 151.18%142.7M | ---- | -426.06%-278.84M | ---- | -47.47%85.52M | ---- | 227.82%162.82M | ---- |
-Other fair value changes | -77.71%31.81M | ---- | 151.18%142.7M | ---- | -426.06%-278.84M | ---- | -47.47%85.52M | ---- | 227.82%162.82M | ---- |
Asset sale loss (gain): | 726.96%16.44M | ---- | 104.57%1.99M | ---- | -482.75%-43.52M | ---- | 6,990.30%11.37M | ---- | 99.56%-165K | ---- |
-Loss (gain) from sale of subsidiary company | --15.13M | ---- | ---- | ---- | -494.73%-44.08M | ---- | --11.17M | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | -34.15%1.31M | ---- | 251.86%1.99M | ---- | 179.70%565K | ---- | 222.42%202K | ---- | -105.60%-165K | ---- |
Depreciation and amortization: | -9.78%53.91M | ---- | -38.90%59.75M | ---- | 20.48%97.8M | ---- | -35.21%81.17M | ---- | 31.51%125.29M | ---- |
-Depreciation | -32.76%29.84M | ---- | -46.33%44.38M | ---- | 25.86%82.68M | ---- | -34.01%65.69M | ---- | 22.02%99.55M | ---- |
-Amortization of intangible assets | 41.01%20.04M | ---- | 1.81%14.21M | ---- | -5.74%13.96M | ---- | -42.48%14.81M | ---- | 88.15%25.74M | ---- |
Financial expense | -63.97%-178.25M | ---- | -37.11%-108.71M | ---- | 5.10%-79.29M | ---- | 36.65%-83.55M | ---- | 43.17%-131.87M | ---- |
Special items | -64.12%120.27M | ---- | 140.31%335.18M | ---- | -0.91%139.48M | ---- | 23.54%140.76M | ---- | 271.38%113.94M | ---- |
Operating profit before the change of operating capital | 104.84%712.2M | ---- | 1.15%347.69M | ---- | -0.51%343.73M | ---- | 441.80%345.49M | ---- | 80.32%-101.08M | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 135.24%7.37M | ---- | -17.28%-20.91M | ---- | ---17.83M | ---- | ---- | ---- | 587.50%660K | ---- |
Accounts receivable (increase)decrease | -312.27%-606.07M | ---- | 164.98%285.52M | ---- | 16.87%-439.42M | ---- | -224.32%-528.61M | ---- | 71.49%-162.99M | ---- |
Accounts payable increase (decrease) | 2,946.84%993.32M | ---- | 71.56%-34.89M | ---- | -142.08%-122.69M | ---- | 114.37%291.58M | ---- | 340.96%136.02M | ---- |
Financial liabilities at fair value (increase)decrease | -141.38%-5.4M | ---- | --13.05M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items for working capital changes | 11,450.27%215.99M | ---- | 100.68%1.87M | ---- | -270.65%-273.13M | ---- | 125.08%160.05M | ---- | -109.96%-638.2M | ---- |
Cash from business operations | 49.29%869.02M | 610.12%1.23B | 214.29%582.1M | 131.30%172.97M | -289.68%-509.33M | -411.07%-552.65M | 135.07%268.52M | 83.79%-108.14M | 43.64%-765.59M | -118.48%-667.27M |
Other taxs | -2,594.48%-46.83M | 40.94%-554K | -114.86%-1.74M | -208.31%-938K | 428.17%11.7M | --866K | 66.23%-3.56M | ---- | 43.02%-10.56M | 92.59%-1.06M |
Net cash from operations | 41.67%822.19M | 613.67%1.23B | 216.62%580.36M | 131.18%172.03M | -287.82%-497.63M | -410.27%-551.79M | 134.14%264.95M | 83.82%-108.14M | 43.63%-776.15M | -109.02%-668.33M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 32.12%156.34M | 32.53%62.43M | 63.92%118.33M | 25.44%47.11M | -19.21%72.19M | -24.77%37.55M | -63.43%89.35M | -71.92%49.91M | 55.83%244.33M | 98.36%177.74M |
Dividend received - investment | ---- | ---- | ---- | ---- | --59.89M | ---- | ---- | ---- | ---- | ---- |
Loan receivable (increase) decrease | -124.20%-177.5M | ---175M | ---79.17M | ---- | ---- | ---- | -102.30%-20M | -104.00%-20M | 216.24%871.08M | --500M |
Decrease in deposits (increase) | -884.78%-2.95B | ---821.28M | ---300M | ---- | ---- | ---- | -82.94%120.77M | -103.07%-25.91M | -61.54%708.02M | 22.75%842.87M |
Sale of fixed assets | -30.58%940K | 429.09%291K | -64.34%1.35M | -98.42%55K | 126,466.67%3.8M | --3.48M | -99.25%3K | ---- | -71.79%398K | 101.36%594K |
Purchase of fixed assets | -2.29%-9.79M | 47.83%-2.51M | 37.68%-9.57M | 36.12%-4.82M | 31.05%-15.36M | -306.53%-7.54M | -106.04%-22.28M | 78.93%-1.85M | 78.63%-10.81M | 61.85%-8.8M |
Purchase of intangible assets | -633.68%-2.09M | -1,141.57%-2.06M | 75.70%-285K | -176.67%-166K | -555.31%-1.17M | ---60K | 82.62%-179K | ---- | 87.26%-1.03M | ---1.71M |
Sale of subsidiaries | --965K | ---- | ---- | ---- | --138.58M | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | 69,273.60%2.08B | ---- | 0.00%-3M | 0.00%-3M | 25.00%-3M | 25.00%-3M | ---4M | ---4M | ---- | ---- |
Recovery of cash from investments | -8.56%1.11B | -25.00%4.5M | 4,892.21%1.22B | -95.85%6M | -90.19%24.35M | 118,318.03%144.47M | --248.2M | --122K | ---- | ---- |
Cash on investment | 58.84%-500M | ---- | -6,942.75%-1.21B | -183.33%-14.88M | 95.17%-17.25M | 93.44%-5.25M | -310.41%-357.5M | -132.88%-80M | 86.04%-87.11M | 70.13%-34.35M |
Other items in the investment business | ---- | ---- | --38.88M | ---- | ---- | ---- | ---- | 176.18%80.05M | -111.00%-59.38M | 82.11%-105.08M |
Net cash from investment operations | -28.34%-298.76M | -3,180.88%-933.63M | -188.84%-232.78M | -82.14%30.3M | 381.93%262.02M | 10,180.33%169.65M | -96.74%54.37M | -100.12%-1.68M | 52.80%1.67B | 2,576.82%1.37B |
Net cash before financing | 50.59%523.43M | 45.36%294.1M | 247.52%347.58M | 152.95%202.33M | -173.79%-235.62M | -247.97%-382.14M | -64.09%319.32M | -115.62%-109.82M | 410.03%889.34M | 361.78%702.92M |
Cash flow from financing activities | ||||||||||
Refund | ---- | ---- | 54.55%-9.38M | -25.00%-9.38M | 94.33%-20.63M | 97.91%-7.5M | -1.14%-363.55M | -14,242.00%-358.55M | -11,881.17%-359.44M | -66.67%-2.5M |
Issuing shares | ---- | ---- | ---- | ---- | -85.89%1.56M | -83.21%1.56M | 175.87%11.07M | 155.39%9.3M | --4.01M | --3.64M |
Interest paid - financing | ---- | ---- | 98.70%-15K | 30.93%-469K | 80.42%-1.15M | 85.37%-679K | 80.19%-5.87M | 62.57%-4.64M | -101.95%-29.65M | -242.35%-12.4M |
Dividends paid - financing | ---3.42M | ---3.42M | ---- | ---- | 13.53%-1.87M | 13.53%-1.87M | ---2.17M | ---2.17M | ---- | ---- |
Other items of the financing business | -131.52%-90.13M | 11.05%-16.3M | 33.31%-38.93M | 66.23%-18.32M | -114.38%-58.38M | -380.44%-54.27M | 22.42%-27.23M | -312.98%-11.3M | -192.65%-35.1M | -317.24%-2.74M |
Net cash from financing operations | -93.60%-93.55M | 30.00%-19.72M | 39.94%-48.32M | 55.12%-28.17M | 79.25%-80.46M | 82.92%-62.76M | 7.72%-387.75M | -1,166.58%-367.35M | -123.80%-420.18M | -104.17%-29M |
Effect of rate | -21.65%64.29M | -32.71%79.01M | 288.58%82.05M | 1,547.85%117.42M | -13.63%-43.51M | 89.27%-8.11M | -119.75%-38.29M | -162.28%-75.6M | 9.35%193.89M | -46.16%121.4M |
Net Cash | 43.65%429.88M | 57.54%274.39M | 194.68%299.26M | 139.15%174.17M | -361.87%-316.08M | 6.76%-444.89M | -114.59%-68.43M | -170.80%-477.17M | -68.27%469.17M | 57.81%673.92M |
Begining period cash | 10.78%3.92B | 10.78%3.92B | -9.23%3.54B | -9.23%3.54B | -2.67%3.9B | -2.67%3.9B | 19.84%4B | 19.84%4B | 98.22%3.34B | 98.22%3.34B |
Cash at the end | 12.61%4.41B | 11.57%4.27B | 10.78%3.92B | 11.18%3.83B | -9.23%3.54B | -0.20%3.44B | -2.67%3.9B | -16.56%3.45B | 19.84%4B | 76.92%4.14B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.